Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89501-89550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05220800
Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer
PHASE2Not yet recruiting
134 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2029
2 conditions3 sponsors3 locations
NCT05346510
Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer
NARecruiting
500 participants
Started: Mar 1, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05573295
Dental Age Estimation by Different Methods in Patients With Cleft Lip and Palate
N/ARecruiting
240 participants
Started: Mar 1, 2022 · Completed: Dec 15, 2024
2 conditions1 sponsor1 location
NCT05230329
CME Versus Standard Right Hemicolectomy for Right Sided Cancers
N/ANot yet recruiting
330 participants
Started: Mar 1, 2022 · Completed: Feb 1, 2028
1 condition1 sponsor1 location
NCT05996354
Concave Supra-arch Branched Stent-Graft System for Treatment of Aortic Arch Diseases
NAActive, not recruiting
10 participants
Started: Mar 1, 2022 · Completed: Apr 30, 2025
5 conditions1 sponsor3 locations
NCT05427799
The Influence of Daily Honey Consumption on IR in Obese Women with IR
NARecruiting
60 participants
Started: Mar 1, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors2 locations
NCT05235737
The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PHASE4Recruiting
36 participants
Started: Mar 1, 2022 · Completed: May 30, 2026
1 condition2 sponsors1 location
NCT06105073
"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"
N/ARecruiting
67 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2024
1 condition1 sponsor1 location
NCT05185531
A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma
PHASE1Active, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05094843
The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery
N/ARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT05728320
Glycemic Patterns After Bariatric Surgery and High Glycemic Variability and Hypoglycemia Unawareness Risk Factors
N/ARecruiting
200 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05257954
Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.
N/ARecruiting
500 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2029
2 conditions1 sponsor1 location
NCT06354335
Impact of a Major Organizational Change on Employee Productivity and Mental Health
N/AActive, not recruiting
31,555 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
3 conditions4 sponsors1 location
NCT05425251
BRAINI-2 Elderly Mild TBI European Study
N/ARecruiting
2,850 participants
Started: Mar 1, 2022 · Completed: Mar 30, 2025
1 condition7 sponsors7 locations
NCT05177731
"Venetoclax + Decitabine vs. 7+3 Induction Chemotherapy in Young AML"
PHASE3Active, not recruiting
188 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05246215
Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients
N/ANot yet recruiting
90 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2026
3 conditions1 sponsor0 locations
NCT05475769
NUMITOR Study: Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World Setting
N/ARecruiting
98 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
7 conditions1 sponsor1 location
NCT05180812
Safety and Feasibility of ExoNET
NAActive, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Jul 12, 2026
2 conditions1 sponsor1 location
NCT05270824
Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma
PHASE3Not yet recruiting
120 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2027
3 conditions1 sponsor0 locations
NCT05652608
Stronger Together Psoriatic Arthritis Wellness Study
N/ARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2026
1 condition2 sponsors1 location
NCT05042791
A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
PHASE2Recruiting
362 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT03568292
Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures
NARecruiting
60 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2027
1 condition3 sponsors1 location
NCT06092255
A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM.
NARecruiting
40 participants
Started: Mar 1, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04201600
Glucose Variability and Cognition in Prediabetes
N/ARecruiting
30 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
6 conditions3 sponsors1 location
NCT05285280
Echocardiography in Men With Erectile Dysfunction
N/AActive, not recruiting
386 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2032
3 conditions1 sponsor1 location
NCT05165537
Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques
NARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05260905
Predictors of Affective Responses to Sprint Interval Exercise
N/AActive, not recruiting
150 participants
Started: Mar 1, 2022 · Completed: Aug 31, 2025
1 condition5 sponsors1 location
NCT05250973
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
PHASE2Active, not recruiting
151 participants
Started: Mar 1, 2022 · Completed: Mar 2, 2027
1 condition1 sponsor46 locations
NCT04394806
The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy
N/ARecruiting
140 participants
Started: Mar 1, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05201833
TRACK-TBI Longitudinal Biomarker Study
N/AActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2027
1 condition3 sponsors11 locations
NCT05527132
Understanding the Phenomena of Aging and Rupture of Breast Implants
N/ARecruiting
50 participants
Started: Feb 28, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04871009
A Trial of Neurofeedback As an Adjunctive Treatment for Youth in Outpatient Mental Health Settings
NARecruiting
40 participants
Started: Feb 28, 2022 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06119542
Endothelial Damage in Major Spine Surgery, Measured by Circulating Syndecan-1: an Observational Study.(GlycOrtho)
N/ARecruiting
30 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05031325
Efficacy of a Hemostatic Agent (PuraStat®) in Reducing Delayed Bleeding After Endoscopic Submucosal Dissection
NARecruiting
288 participants
Started: Feb 28, 2022 · Completed: Dec 26, 2024
1 condition1 sponsor1 location
NCT05224102
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
PHASE4Active, not recruiting
218 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor43 locations
NCT05172284
Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases
N/ANot yet recruiting
2,000 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04824053
Effects of UNICLA-A2 Dairy Products on Patients At High-risk of Colorectal Cancer Development
NARecruiting
34 participants
Started: Feb 28, 2022 · Completed: Dec 15, 2026
1 condition3 sponsors1 location
NCT05177289
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
NARecruiting
72 participants
Started: Feb 28, 2022 · Completed: Jan 31, 2030
1 condition1 sponsor1 location
NCT05072015
Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
N/ANot yet recruiting
150 participants
Started: Feb 28, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT05202951
Chronic Pain and Hemophilia
N/ARecruiting
350 participants
Started: Feb 28, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor10 locations
NCT05076214
Aerobic Versus Leisure Group for Adolescents With Depression
NARecruiting
122 participants
Started: Feb 28, 2022 · Completed: Mar 10, 2026
1 condition7 sponsors4 locations
NCT05097885
Health Benefits of Whole-body Vibration
NARecruiting
40 participants
Started: Feb 28, 2022 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT05131399
Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment
NARecruiting
20 participants
Started: Feb 28, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor8 locations
NCT05246722
Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease (PHARM-ageing)
N/ANot yet recruiting
15,000 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor0 locations
NCT05412758
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)
NARecruiting
648 participants
Started: Feb 28, 2022 · Completed: Oct 31, 2025
10 conditions21 sponsors1 location
NCT05014971
Telehealth in Lewy Body Dementia
NARecruiting
106 participants
Started: Feb 28, 2022 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT05036707
Human Immune Response to Ixodes Scapularis Tick Bites
PHASE1/PHASE2Recruiting
60 participants
Started: Feb 28, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05063916
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
PHASE2Active, not recruiting
18 participants
Started: Feb 28, 2022 · Completed: Aug 1, 2027
3 conditions1 sponsor1 location
NCT05040568
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
PHASE1Active, not recruiting
15 participants
Started: Feb 28, 2022 · Completed: Feb 2, 2027
2 conditions1 sponsor1 location
NCT05868837
Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
PHASE3Recruiting
40 participants
Started: Feb 28, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location